Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines
Thomas C. Mitchell, Carolyn R. Casella
Current Opinion in Immunology (2017) Vol. 47, pp. 17-25
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

The how’s and what’s of vaccine reactogenicity
Caroline Hervé, Béatrice Laupèze, Giuseppe Del Giudice, et al.
npj Vaccines (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 416
Human Papillomavirus Vaccines: An Updated Review
Liqin Cheng, Yan Wang, Juan Du
Vaccines (2020) Vol. 8, Iss. 3, pp. 391-391
Open Access | Times Cited: 225
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
Yicheng Mo, Jiabing Ma, Hongtao Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 95
Updates on cervical cancer prevention
David Viveros‐Carreño, Andreína Fernándes, René Pareja
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 394-402
Closed Access | Times Cited: 52
Novel approaches for the design, delivery and administration of vaccine technologies
Jamie Wallis, Daniel P. Shenton, Robert Carlisle
Clinical & Experimental Immunology (2019) Vol. 196, Iss. 2, pp. 189-204
Open Access | Times Cited: 112
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si’Ana A. Coggins, Eric D. Laing, Cara Olsen, et al.
Open Forum Infectious Diseases (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 66
Can reactogenicity predict immunogenicity after COVID-19 vaccination?
Young Hoon Hwang, Kyoung‐Ho Song, Yunsang Choi, et al.
The Korean Journal of Internal Medicine (2021) Vol. 36, Iss. 6, pp. 1486-1491
Open Access | Times Cited: 56
mRNA Cancer Vaccines: Construction and Boosting Strategies
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 40
Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
Brankica Filipić, Ivana Pantelić, Ines Nikolić, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1172-1172
Open Access | Times Cited: 34
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
Lei‐Ming Cao, Yifu Yu, Zi‐Zhan Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Biodegradable Polymers for Application as Robust Immunomodulatory Biomaterial Carrier Systems
Brian George Barbery, Nicole Rose Lukesh, Eric M. Bachelder, et al.
Small (2025)
Closed Access | Times Cited: 1
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded
Sogand Amiri, Shiva Rasekh, Seyed Mohammad Iman Moezzi, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
MPL Adjuvant Contains Competitive Antagonists of Human TLR4
Yiqi Wang, Hélène G. Bazin, Jay T. Evans, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 62
COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience
Alfred Chung Pui So, Harriet McGrath, Jonathan Y. Ting, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3573-3573
Open Access | Times Cited: 52
Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
Stilla Bauernfeind, Bernd Salzberger, Florian Hitzenbichler, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1089-1089
Open Access | Times Cited: 44
Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy
Jia Tan, Binbin Ding, Bo Teng, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 16
Closed Access | Times Cited: 37
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Jürgen Held, Jan Esse, Koray Taşçılar, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1063-1063
Open Access | Times Cited: 35
Dendritic Mesoporous Silica Nanoparticle Adjuvants Modified with Binuclear Aluminum Complex: Coordination Chemistry Dictates Adjuvanticity
Yang Yang, Jie Tang, Hao Song, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 44, pp. 19610-19617
Closed Access | Times Cited: 33
Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers
Jade Z. Zhou, Jessica Jou, Ezra E.W. Cohen
Cancers (2021) Vol. 14, Iss. 1, pp. 33-33
Open Access | Times Cited: 27
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?
Maria Gabriella Matera, Carlo Capristo, Vito de Novellis, et al.
Expert Review of Anti-infective Therapy (2025)
Closed Access
Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development
Abdullah R. Alrasheed, Maaweya Awadalla, Hadeel Alnajran, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious Diseases
F. Heath Damron, Mariette Barbier, Purnima Dubey, et al.
The Journal of Immunology (2020) Vol. 205, Iss. 4, pp. 877-882
Open Access | Times Cited: 28
RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion
Caroline C. Krueger, Franziska Thoms, Elsbeth Keller, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 27
The trehalose glycolipid C18Brar promotes antibody and T-cell immune responses to Mannheimia haemolytica and Mycoplasma ovipneumoniae whole cell antigens in sheep
Sandeep Gupta, Natalie A. Parlane, Benjamin Bridgeman, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0278853-e0278853
Open Access | Times Cited: 8
ACTIVE SURVEILLANCE OF THE SPUTNIK V VACCINE IN HEALTH WORKERS
Vanina Pagotto, Analía Ferloni, M.M. Soriano, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top